Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors

Clinical trial NCT05662852 · COMPLETED

Trial details

NCT number: NCT05662852
Sponsor: ABO Holdings, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus, Diphtheria and Acellular Pertussis Vaccination

Start date: 2023-05-05
Primary completion: 2025-05-12
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.